AAAAAA

   
Results: 1-23 |
Results: 23
Anticardiolipin and anti-beta 2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits
Authors: Avcin, T Ambrozic, A Kuhar, M Kveder, T Rozman, B
Citation: T. Avcin et al., Anticardiolipin and anti-beta 2 glycoprotein I antibodies in sera of 61 apparently healthy children at regular preventive visits, RHEUMATOLOG, 40(5), 2001, pp. 565-573
Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies including Therapeutic Trials (ESCISIT)
Authors: Swaak, AJG van de Brink, H Smeenk, RJT Manger, K Kalden, JR Tosi, S Marchesoni, A Domljan, Z Rozman, B Logar, D Pokorny, G Kovacs, L Kovacs, A Vlachoyiannopoulos, PG Moutsopoulos, HM Chwalinska-Sadowska, H Dratwianka, B Kiss, E Cikes, N Anic, B Schneider, M Fischer, R Bombardieri, S Mosca, M Graninger, W Smolen, JS
Citation: Ajg. Swaak et al., Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies including Therapeutic Trials (ESCISIT), RHEUMATOLOG, 40(1), 2001, pp. 89-94
Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation
Authors: Swaak, AJG van den Brink, HG Smeenk, RJT Manger, K Kalden, JR Tosi, S Domljan, Z Rozman, B Logar, D Pokorny, G Kovacs, L Kovacs, A Vlachoyiannopoulos, PG Moutsopoulos, HM Chwalinska-Sadowska, H Kiss, E Cikes, N Anic, B Schneider, M Fischer, R Bombardieri, S Mosca, M Graninger, W Smolen, JS
Citation: Ajg. Swaak et al., Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation, LUPUS, 10(1), 2001, pp. 51-58
Secondary hyperparathyroidism and brown tumor in dialyzed patients
Authors: Jeren-Strujic, B Rozman, B Lambasa, S Jeren, T Markovic, M Raos, V
Citation: B. Jeren-strujic et al., Secondary hyperparathyroidism and brown tumor in dialyzed patients, RENAL FAIL, 23(2), 2001, pp. 279-286
Improved functional ability in patients with rheumatoid arthritis - Longterm treatment with leflunomide versus sulfasalazine
Authors: Kalden, JR Scott, DL Smolen, JS Schattenkirchner, M Rozman, B Williams, BD Kvien, TK Jones, P Williams, RB Oed, C Rosenburg, R
Citation: Jr. Kalden et al., Improved functional ability in patients with rheumatoid arthritis - Longterm treatment with leflunomide versus sulfasalazine, J RHEUMATOL, 28(9), 2001, pp. 1983-1991
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine
Authors: Larsen, A Kvien, TK Schattenkirchner, M Rau, R Scott, DL Smolen, JS Rozman, B Westhovens, R Tikly, M Oed, C Rosenburg, R
Citation: A. Larsen et al., Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine, SC J RHEUM, 30(3), 2001, pp. 135-142
Classification of anti-endothelial cell antibodies into antibodies againstmicrovascular and macrovascular endothelial cells - The pathogenic and diagnostic implications
Authors: Praprotnik, S Blank, M Meroni, PL Rozman, B Eldor, A Shoenfeld, Y
Citation: S. Praprotnik et al., Classification of anti-endothelial cell antibodies into antibodies againstmicrovascular and macrovascular endothelial cells - The pathogenic and diagnostic implications, ARTH RHEUM, 44(7), 2001, pp. 1484-1494
Re: Tager and Tikly. Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans
Authors: Rozman, B Kveder, T
Citation: B. Rozman et T. Kveder, Re: Tager and Tikly. Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans, RHEUMATOLOG, 39(2), 2000, pp. 220-221
Marginal erosive discovertebral "Romanus" lesions in ankylosing spondylitis demonstrated by contrast enhanced Gd-DTPA magnetic resonance imaging
Authors: Jevtic, V Kos-Golja, M Rozman, B McCall, I
Citation: V. Jevtic et al., Marginal erosive discovertebral "Romanus" lesions in ankylosing spondylitis demonstrated by contrast enhanced Gd-DTPA magnetic resonance imaging, SKELETAL RA, 29(1), 2000, pp. 27-33
Determinants of reduced bone mineral density and increased bone turnover after kidney transplantation: Cross-sectional study
Authors: Kusec, V Smalcelj, R Cvijetic, S Rozman, B Skreb, F
Citation: V. Kusec et al., Determinants of reduced bone mineral density and increased bone turnover after kidney transplantation: Cross-sectional study, CROAT MED J, 41(4), 2000, pp. 396-400
Autoimmune systemic diseases - a hot topic for clinicians and pathologists- Preface
Authors: Rozman, B Ferluga, D Vizjak, A
Citation: B. Rozman et al., Autoimmune systemic diseases - a hot topic for clinicians and pathologists- Preface, WIEN KLIN W, 112(15-16), 2000, pp. 649-649
Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis
Authors: Praprotnik, S Rozman, B Blank, M Shoenfeld, Y
Citation: S. Praprotnik et al., Pathogenic role of anti-endothelial cell antibodies in systemic vasculitis, WIEN KLIN W, 112(15-16), 2000, pp. 660-664
Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases
Authors: Vizjak, A Nagode, B Rott, N Koselj, M Rozman, B Kaplan-Pavlovcic, S Kosnik, M Petric, V Ferluga, D
Citation: A. Vizjak et al., Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases, WIEN KLIN W, 112(15-16), 2000, pp. 665-670
Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE
Authors: Ferluga, D Jerse, M Vizjak, A Hvala, A Rozman, B Kos-Golja, M Bren, AF
Citation: D. Ferluga et al., Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE, WIEN KLIN W, 112(15-16), 2000, pp. 692-701
Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome
Authors: Sipek-Dolnicar, A Hojnik, M Rozman, B Vizjak, A Ferluga, D
Citation: A. Sipek-dolnicar et al., Small vessel thrombosis without major thrombotic events in systemic lupus erythematosus patients with antiphospholipid syndrome, WIEN KLIN W, 112(15-16), 2000, pp. 707-710
Immunoserological aspects of idiopathic inflammatory muscle disease
Authors: Rozman, B Bozic, B Kos-Golja, M Plesivcnik-Novljan, M Kveder, T
Citation: B. Rozman et al., Immunoserological aspects of idiopathic inflammatory muscle disease, WIEN KLIN W, 112(15-16), 2000, pp. 722-727
Sjogren's syndrome: a community-based study of prevalence and impact - comment on the article by Thomas et al.
Authors: Tomsic, M Rozman, B
Citation: M. Tomsic et B. Rozman, Sjogren's syndrome: a community-based study of prevalence and impact - comment on the article by Thomas et al., RHEUMATOLOG, 38(7), 1999, pp. 685-686
Systemic lupus erythematosus: clinical features in patients with a diseaseduration of over 10 years, first evaluation
Authors: Swaak, AJG van den Brink, HG Smeenk, RJT Manger, K Kalden, JR Tosi, S Marchesoni, A Domljan, Z Rozman, B Logar, D Pokorny, G Kovacs, L Kovacs, A Vlachoyiannopoulos, PG Moutsopoulos, HM Chwalinska-Sadowska, H Dratwianka, B Kiss, E Cikes, N Branimir, A Schneider, M Fischer, R Bombardieri, S Mosca, M Graninger, W Smolen, JS
Citation: Ajg. Swaak et al., Systemic lupus erythematosus: clinical features in patients with a diseaseduration of over 10 years, first evaluation, RHEUMATOLOG, 38(10), 1999, pp. 953-958
Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjogren's syndrome: A prospective study
Authors: Praprotnik, S Bozic, B Kveder, T Rozman, B
Citation: S. Praprotnik et al., Fluctuation of anti-Ro/SS-A antibody levels in patients with systemic lupus erythematosus and Sjogren's syndrome: A prospective study, CLIN EXP RH, 17(1), 1999, pp. 63-68
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial
Authors: Smolen, JS Kalden, JR Scott, DL Rozman, B Kvien, TK Larsen, A Loew-Friedrich, I Oed, C Rosenburg, R
Citation: Js. Smolen et al., Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial, LANCET, 353(9149), 1999, pp. 259-266
Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al - Reply
Authors: Bresnihan, B Alvaro-Gracia, JM Cobby, M Doherty, M Domljan, Z Emery, P Nuki, G Pavelka, K Rau, R Rozman, B Watt, I Williams, B Aitchison, R McCabe, D Musikic, P
Citation: B. Bresnihan et al., Blindedness in clinical trials of therapies for rheumatoid arthritis: comment on the article by Bresnihan et al - Reply, ARTH RHEUM, 42(8), 1999, pp. 1782-1782
Unusual occurrence of acute low back pain in a patient with ruptured urachal cyst
Authors: Ambrozic, A Praprotnik, S Rozman, B
Citation: A. Ambrozic et al., Unusual occurrence of acute low back pain in a patient with ruptured urachal cyst, BR J RHEUM, 37(12), 1998, pp. 1354-1355
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
Authors: Bresnihan, B Alvaro-Gracia, JM Cobby, M Doherty, M Domljan, Z Emery, P Nuki, G Pavelka, K Rau, R Rozman, B Watt, I Williams, B Aitchison, R McCabe, D Musikic, P
Citation: B. Bresnihan et al., Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist, ARTH RHEUM, 41(12), 1998, pp. 2196-2204
Risultati: 1-23 |